Therefore it may reduce IL-32 expression in T1D through decreased IFNγ signaling; however, as Abatacept also decreases abundance of Tregs the overall balance of its effect on IL-32 levels should also be determined (76). This evidence concerns the gene IFNG and type 1 diabetes mellitus.